Charlie’s Law: Increased Access to Stem Cell Interventions in Texas

On October fourth, the Texas Heart Institute and Rice University’s Baker Institute for Health and Biosciences will host a panel discussion on Texas H.B. 810, or “Charlie’s Law,” which was passed in the 85th Texas Legislative Session. Charlie’s Law expands the right-to-try laws in Texas so that patients with chronic and terminal illnesses can have access to experimental stem cell interventions. The Panelists will discuss how Charlie’s Law will affect research and health care as well as how to protect patients moving forward.

INTRODUCTION

James T. Willerson, M.D.
President Emeritus, Texas Heart Institute

PANELISTS

The Honorable Paul Bettencourt
Texas State Senator, District 7

The Honorable Garnet Coleman
Texas State Representative, District 147

The Honorable Tan Parker
Texas State Representative, District 63

Doris A. Taylor, Ph.D.
Director, Regenerative Medicine Research, Texas Heart® Institute

The Honorable Charles Schwertner, M.D.
Texas State Senator, District 5

The Honorable John Zerwas
Texas State Representative, District 28

MODERATOR

Kirstin R.W. Matthews, Ph.D.
Fellow in Science and Technology Policy, Baker Institute